Page 1 |
Save page Remove page | Previous | 1 of 117 | Next |
|
small (250x250 max)
medium (500x500 max)
large ( > 500x500)
Full Resolution
All (PDF)
|
This page
All
Subset |
RATIONALIZED IMMUNOTHERAPY BY IMMUNE SIGNATURE CHARACTERIZATION
by
Rebecca Eli Sadun
A Dissertation Presented to the
FACULTY OF THE GRADUATE SCHOOL
UNIVERSITY OF SOUTHERN CALIFORNIA
In Partial Fulfillment of the
Requirements for the Degree
DOCTOR OF PHILOSOPHY
(PATHOBIOLOGY)
August 2007
Copyright 2007 Rebecca Eli Sadun
Object Description
| Title | Rationalized immunotherapy by immune signature characterization |
| Author | Sadun, Rebecca Eli |
| Author email | sadun@usc.edu |
| Degree | Doctor of Philosophy |
| Document type | Dissertation |
| Degree program | Pathobiology |
| School | Keck School of Medicine |
| Date defended/completed | 2007-04-18 |
| Date submitted | 2007 |
| Restricted until | Unrestricted |
| Date published | 2007-06-11 |
| Advisor (committee chair) | Epstein, Alan L. |
| Advisor (committee member) |
Hofman, Florence M. Kast, W. Martin Stallcup, Michael R. Yang, Allen S. |
| Abstract | Great strides in the understanding of cancer biology have provided a multitude of approaches to the medical treatment of cancer. While chemotherapy alone has succeeded in making many malignancies into treatable diseases, certain cancers remain elusive despite the current arsenal, and for many patients the toxicities of chemotherapies are intolerable or even fatal. One attractive alternative to chemotherapy is cancer immunotherapy, an approach that seeks to harness the power of the immune system to treat cancer. Despite achieving only modest clinical successes to-date, immunotherapy offers the promise of a physiological treatment as opposed to a treatment based on semi-selective toxicity. This manuscript begins by describing a new murine immunotherapeutic reagent, constructed by genetically linking the antibody Fc backbone to the molecule OX40L, which can provide a T cell activating second-signal and simultaneously inhibit the effects of suppressor T cells known as Tregs. The resultant Fc-mOX40L fusion protein has demonstrated striking anti-tumor effects in two murine experimental tumor models. Though similar fusion protein strategies have been described in the literature, this manuscript goes on to describe a novel approach to delineating tumors' "escape" strategies and identifying the immunotherapy with the greatest capacity for impeding those mechanisms of tumor escape. Using real-time PCR, it was possible to create immune signatures that characterize the T cell activation profile of five murine tumor models as well as human breast and colorectal tumor specimens. This technique identified several cancer-induced immunotherapy targets in human ductal adenocarcinoma of the breast, including high expression of immunoinhibitory B7-H4 and low expression of immune activating CD28 and CD83.; Finally, this manuscript describes how our "immunotyping" approach was used to reveal the immunological mechanisms of action of a combination immunotherapy regimen known to producedifferential responses in different murine tumor models. Ultimately, the degree of Treg cell involvement was identified as the determining factor for the degree of response to treatment. Though the age of "personalized medicine" has been considered by many to be a pipedream with respect to complex diseases like cancer, the technology and analysis herein described make a case for rationalized immunotherapeutics being close on the horizon. |
| Keyword | cancer; oncology; tumor escape; immunosurveillance; tolerance; immunoeditting; biomarkers; real-time PCR |
| Language | English |
| Part of collection | University of Southern California dissertations and theses |
| Publisher (of the original version) | University of Southern California |
| Place of publication (of the original version) | Los Angeles, California |
| Publisher (of the digital version) | University of Southern California. Libraries |
| Type | texts |
| Legacy record ID | usctheses-m524 |
| Rights | Sadun, Rebecca Eli |
| Repository name | Libraries, University of Southern California |
| Repository address | Los Angeles, California |
| Repository email | http://www.usc.edu/isd/libraries/services/ask_a_librarian/email/ |
| Filename | etd-Sadun-20070611 |
| Archival file | uscthesesreloadpub_Volume23/etd-Sadun-20070611.pdf |
Description
| Title | Page 1 |
| Full text | RATIONALIZED IMMUNOTHERAPY BY IMMUNE SIGNATURE CHARACTERIZATION by Rebecca Eli Sadun A Dissertation Presented to the FACULTY OF THE GRADUATE SCHOOL UNIVERSITY OF SOUTHERN CALIFORNIA In Partial Fulfillment of the Requirements for the Degree DOCTOR OF PHILOSOPHY (PATHOBIOLOGY) August 2007 Copyright 2007 Rebecca Eli Sadun |
Comments
Post a Comment for Page 1
